184 related articles for article (PubMed ID: 6221540)
21. Vasodilator and antiplatelet activities of prostacyclins with modified omega-side chain.
Schölkens BA; Bartmann W; Beck G; Lerch U; Konz E; Weithmann U
Adv Prostaglandin Thromboxane Res; 1980; 6():341-5. PubMed ID: 6992533
[No Abstract] [Full Text] [Related]
22. Prostaglandins E1 and E2, but neither prostacyclin nor prostaglandin D2 have anti-aggregating activity in chicken blood.
Bult H; Wechsung E; Houvenaghel A; Herman AG
Arch Int Pharmacodyn Ther; 1981 Feb; 249(2):306-8. PubMed ID: 7013724
[No Abstract] [Full Text] [Related]
23. Prostaglandins as inhibitors of human platelet aggregation.
Di Minno G; Silver MJ; de Gaetano G
Br J Haematol; 1979 Dec; 43(4):637-47. PubMed ID: 393296
[TBL] [Abstract][Full Text] [Related]
24. [Prostaglandins and arteriosclerosis. Action of PGI 2 (PGX) on platelet aggregation].
Messini M; Messini F
Clin Ter; 1979 Jul; 90(1):3-9. PubMed ID: 394908
[No Abstract] [Full Text] [Related]
25. Effects of prostacyclin, 6-keto-PGF1 alpha PGF2 alpha and 15[S]15-methyl-PGF2 alpha on platelet aggregation in vitro.
Marmo E; Somma A; Ottavo R; Vairo G; Spaziante G; DiMezza F; Paone G
J Med; 1981; 12(2-3):97-108. PubMed ID: 7024451
[No Abstract] [Full Text] [Related]
26. The relative activity of prostacyclin (PGI2) and a stable analogue 6beta-PGI1 on the gastrointestinal and cardiovascular systems.
Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
J Pharm Pharmacol; 1978 Sep; 30(9):597-9. PubMed ID: 29109
[No Abstract] [Full Text] [Related]
27. Effect of prostaglandin I2 and analogs on platelet aggregation and smooth muscle contraction.
Crane BH; Maish TL; Maddox YT; Corey EJ; Székely I; Ramwell PW
J Pharmacol Exp Ther; 1978 Jul; 206(1):132-8. PubMed ID: 351171
[No Abstract] [Full Text] [Related]
28. Inhibition of platelet aggregation and reversal of vasopressin-induced ECG changes by a carboprostacyclin analogue, ONO 41483, in primates.
Adaikan PG; Kottegoda SR; Lau LC; Tai MY; Karim SM
Prostaglandins Leukot Med; 1982 Sep; 9(3):307-20. PubMed ID: 6752959
[TBL] [Abstract][Full Text] [Related]
29. Syntheses and biological activities of some prostacyclin analogs.
Ohuchida S; Hashimoto S; Wakatsuka H; Arai Y; Hayashi M
Adv Prostaglandin Thromboxane Res; 1980; 6():337-40. PubMed ID: 6992532
[No Abstract] [Full Text] [Related]
30. Diphenylmethylazine prostanoids with prostacyclin-like actions on human platelets.
Jones RL; Wilson NH; Marr CG; Muir G; Armstrong RA
J Lipid Mediat; 1993; 6(1-3):405-10. PubMed ID: 8357998
[TBL] [Abstract][Full Text] [Related]
31. Prostaglandin receptors on human platelets. Structure-activity relationships of stimulatory prostaglandins.
MacIntyre DE; Salzman EW; Gordon JL
Biochem J; 1978 Sep; 174(3):921-9. PubMed ID: 215124
[TBL] [Abstract][Full Text] [Related]
32. Effect of sulphated polysaccharides on prostacyclin (prostaglandin I2)-induced inhibition of platelet aggregation [proceedings].
Kindness G; Williamson FB; Long WF
Biochem Soc Trans; 1980 Jun; 8(3):377-9. PubMed ID: 6995209
[No Abstract] [Full Text] [Related]
33. The effect of PGI2 and PGI2 analogues with increased stability on platelet cAMP content and aggregation.
Blaskó G; Nemesánszky E; Szabó G; Stadler I; Pálos LA
Thromb Res; 1980 Mar; 17(5):673-81. PubMed ID: 6247777
[No Abstract] [Full Text] [Related]
34. Pharmacology of platelet-suppressive agents.
Wautier JL; Caen JP
Semin Thromb Hemost; 1979; 5(4):293-315. PubMed ID: 386519
[No Abstract] [Full Text] [Related]
35. In vitro inhibition by endotoxin of the anti-aggregatory action of prostacyclin produced by aortic rings.
Bult H; Herman AG
Arch Int Pharmacodyn Ther; 1978 Aug; 234(2):335-6. PubMed ID: 361006
[No Abstract] [Full Text] [Related]
36. Prostacyclin (PGI2) and the effect of phosphodiesterase inhibitors on platelet aggregation.
Jørgensen KA; Dyerberg J; Stoffersen E
Pharmacol Res Commun; 1979 Jul; 11(7):605-15. PubMed ID: 388470
[No Abstract] [Full Text] [Related]
37. Synthesis and platelet aggregation inhibition activity of a series of enantiomeric bicyclo[3.2.0]heptane-6-oximinoacetic acids (1).
O-Yang C; Kertesz DJ; Kluge AF; Kuenzler P; Li TT; Marx MM; Bruno JJ; Chang LF
Prostaglandins; 1984 Jun; 27(6):851-63. PubMed ID: 6484210
[TBL] [Abstract][Full Text] [Related]
38. Synthesis of thromboxane receptor antagonists with bicyclo[3.1.0]hexane ring systems.
Kamata S; Haga N; Tsuri T; Uchida K; Kakushi H; Arita H; Hanasaki K
J Med Chem; 1990 Jan; 33(1):229-39. PubMed ID: 2136917
[TBL] [Abstract][Full Text] [Related]
39. [The effect of fluorinated prostaglandins on platelet aggregation].
Lakin KM; Makarov VA; Kovalev SG; Petrukhina GN; Serkov IV; Golovanova NK; Bezuglov VV
Eksp Klin Farmakol; 1994; 57(2):39-41. PubMed ID: 8205047
[TBL] [Abstract][Full Text] [Related]
40. Synthesis and biological activity of novel carbacyclins having bicyclic substituents on the omega-chain.
Tomiyama T; Wakabayashi S; Yokota M
J Med Chem; 1989 Aug; 32(8):1988-96. PubMed ID: 2666669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
